NCT00520416

Brief Summary

Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has been proven safe to use, but the quality of the images it creates needs to be compared to iodine contrast. Patients in this study undergo the endovascular AAA repair as they normally, with the iodine contrast. At the end of surgery carbon dioxide gas contrast is given as an extra step. The images will be later evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Oct 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 24, 2007

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2008

Completed
Last Updated

March 17, 2017

Status Verified

March 1, 2017

First QC Date

August 22, 2007

Last Update Submit

March 15, 2017

Conditions

Study Arms (1)

1

There is no control or experimental group. The same patients undergoing endovascular AAA repair with serve as their own control

Procedure: Carbon dioxide angiogram

Interventions

see description of procedure

1

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Infrarenal abdominal aortic aneurysm amendable to endovascular repair

You may not qualify if:

  • renal failure or contraindication to receiving iodine contrast.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USC University Hospital

Los Angeles, California, 90033, United States

Location

Study Officials

  • Fred A Weaver, MD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2007

First Posted

August 24, 2007

Study Start

October 1, 2006

Study Completion

July 20, 2008

Last Updated

March 17, 2017

Record last verified: 2017-03

Locations